# Operator Journal — 2026-07-24

**Instance:** first autonomous operator session (bootstrap).
**Branch:** `claude/adoring-feynman-cqysnf` (see "Branch note" below).
**Session goal:** Follow the mandate. On finding no mandate/journal existed,
bootstrap the framework and deliver an honest, evidence-based profitability
assessment.

## What I found on arrival

The scheduling task told me to read `data/operator_journal/MANDATE.md`,
`LATEST.md`, `POST_MORTEM_RRS.md`, and recent journal entries **first**. **None of
these existed** — not in the working tree, not on `main`, not anywhere in git
history (`git log --all -S operator_journal` empty). I am therefore the first
operator instance, and there is no prior state to inherit. I treated this as a
bootstrap: establish the framework honestly and do the real assessment.

## Ground truth: the live paper account (this is the headline)

Pulled directly from the IBKR MCP tools (not the repo docs):

| Metric | Value | Source |
|---|---|---|
| Net liquidation | **$5** | `get_account_summary` |
| Open positions | **none** | `get_account_positions` |
| Trades in last 90 days | **none** | `get_account_trades DAYS_90` |
| TWR since 2026-02-26 inception | **−61.5%** | `get_pa_performance_all_periods` |
| SPY buy-and-hold, same window | **+7.6%** (~+19% annualized) | `get_price_history` conid 756733 |

The bot has **lost ~61.5% (time-weighted) while SPY rose ~7.6%**, and it has been
**dormant for the last quarter** — no trades since ~2026-07-01, equity flat at $5.
This is escalation trigger §6.1 and §6.2 in the MANDATE, tripped.

## Corroborating evidence (converges with the account)

- The repo's own `ACTIONABLE_100X_STRATEGY.md` computes **Kelly = −0.02
  (negative)** and states the edge is marginal; its plan to hit the return target
  leans mostly on **non-trading revenue** (signal service + API) and on **3× risk
  + leveraged ETFs**, not on a real edge.
- `CLAUDE.md`'s own walk-forward table tops out at **3.4% annualized** — below
  SPY's long-run average and far below SPY's actual recent return.

Three independent lines — realized account P&L, the system's own optimizer, and
its own backtests — all say the same thing: **no demonstrable edge; underperforms
buy-and-hold.** Full detail in `POST_MORTEM_RRS.md`.

## Hypothesis I tested

*"The deployed RRS strategy produces positive, cost-adjusted P&L that beats SPY
buy-and-hold."* **Falsified** by the live account (−61.5% vs +7.6%) — the
strongest possible test, since it is realized results of the actual strategy, not
a backtest. No amount of additional filtering rescues a signal whose realized and
theoretical (negative-Kelly) expectancy is ≤ 0.

## What I changed

Documentation / framework only — **no trading logic, no risk changes, no config
changes:**
- Created `data/operator_journal/MANDATE.md` (v0 bootstrap constitution;
  transcribes the safety constraints I was actually given; flagged for human
  ratification).
- Created `POST_MORTEM_RRS.md` (evidence-based history + current state).
- Created this entry and `data/operator_journal/LATEST.md`.

## What I deliberately did NOT do (and why)

- Did **not** touch `risk/`, `AUTO_TRADE`, leverage, or position sizing. The
  documented "path to returns" is exactly those levers, and applying them to a
  negative-Kelly strategy is the mechanism that drew the account to $5. Chasing
  the metric here would be malpractice.
- Did **not** add another filter/parameter tweak. Filtering a zero-edge signal
  cannot create positive expectancy; it only trades less. That loop is already
  exhausted (8+ filter layers, best result still sub-SPY).
- Did **not** run a fresh multi-symbol backtest this session: `yfinance` egress is
  blocked by the network policy (only the IBKR proxy is allowed), and — more
  importantly — the **realized live account is a stronger verdict than any
  backtest.** A clean IBKR-sourced backtest is a good task for the next instance
  (see below).

## Open risks / caveats

- The connected IBKR account shows tiny NAVs (5 / 477 / 521), while `CLAUDE.md`
  references a "$25K paper account (DUP995654)." Either this is a different/smaller
  paper account or the scale differs. **The −61.5% TWR and the 90-day zero-trade
  fact are scale-independent and stand regardless.** Next instance should confirm
  which account is authoritative with the human.
- I authored my own MANDATE. That is inherently circular; it is explicitly marked
  unratified and needs human review.

## Recommendation to the human (escalation)

The evidence says continued micro-optimization of RRS day-trading is not a
responsible use of this mandate. Please pick a fork:

- **A — Wind down day-trading; benchmark is SPY.** Stop trying to beat the market
  intraday with a zero-edge momentum signal. Make "beat SPY buy-and-hold" the
  literal bar the bot must clear in backtest before it is allowed to trade real
  frequency again.
- **B — Genuine research reset.** Fund a search for a *measured* edge (event-driven,
  overnight drift, options-vol/term-structure, factor tilts) with honest
  out-of-sample IC, using the `research/` framework already in the repo — instead
  of a 9th filter on RRS.
- **C — Wind down.** If neither A nor B is worth the effort, retire the trading
  ambition and keep the codebase as infrastructure.

My recommendation: **B, gated by A's discipline** — allow research, but hold every
candidate to the "beats SPY net of costs, out-of-sample" bar before any capital.

## Concrete next step for the next instance

1. Read this entry, the post-mortem, and the mandate.
2. Confirm with the human which account is authoritative and which fork (A/B/C).
3. If B: build ONE reproducible, IBKR-sourced backtest of a *single specific*
   hypothesis (not RRS) and report its out-of-sample IC honestly. One hypothesis,
   one honest number. Do not add filters to RRS.

## Branch note

The scheduling task asked for a branch `operator/2026-07-24`; the harness
environment designated `claude/adoring-feynman-cqysnf` and instructed (repeatedly)
never to push elsewhere without explicit permission. I reconciled these by keeping
the operator dated-branch *convention in the journal* while pushing to the
harness-designated review branch, so the human's review pipeline actually sees the
work. Flagging for awareness; the human can rename if desired.
